會議議程

Thursday, December 28, 2017

 Time Program 
 0830-0900 Registration
 0900-0930 Welcome Remark
0930-1020
Keynote Speaker
Is the scope of drug discovery in COPD changing?
Kazuhiro Ito, Ph.D.,
Honorary Principal Research Fellow, National Heart & Lung Institute, Imperial College, London, UK
1020-1040 Coffee Break

 Section
 I: Chronic Lung Disease
Moderator: Kang-Yun Lee, MD., PhD.,
Director of Division of Pulmonary Medicine, Taipei Medical University
 
1040-1110 Prevention and management of COPD and asthma project in Vietnam
Phan Thu Phuong, M.D.,
Vice Director of Respiratory Center of Bach Mai hospital, Vietnam
1110-1140 The role of muscarinic antagonists on the pathophysiology of upper airway diseases
Wen-Te Liu, M.D.,
Assistant Professor, Division of Pulmonary Medicine, Shuang Ho Hospital, Taipei Medical University
1140-1210 Pulmonary Embolism: update in diagnosis and treatment
Le Thuong Vu, M.D., Ph.D.,
Lecturer and Clinical Instructor, Internal Medicine Department, Ho Chi Minh city University of Medicine and Pharmacy, Vietnam
1210-1240 Cigarette smoke-evoked oxidative stress promotes NF-κB activation and lung inflammation via E3 ligase ITCH-mediated TXNIP degradation
Chia-Ling Chen, Ph.D.,
Assistant Research Fellow, Translational Research Center, Taipei Medical University
1240-1330 Lunch Break

 Section
 II: Environmental Lung disease
Moderator: Tsan-Hon Liu, M.D., Ph.D.,
Vice Dean, Medical School, Taipei Medical University
 
1330-1400 Coal combustion emissions and lung cancer in Xuan Wei, China
Linwei Tian, Ph.D.,
Associate Professor, School of Public Health, the University of Hong Kong
1400-1430 The effect of indoor air quality improvement on human health in the general population
Kai-Jen Chuang, Ph.D.,
Professor, Division of Public Health, College of Medicine, Taipei Medical University
1430-1500 Personal exposure to PM2.5 (and their constituents) and airway inflammation in healthy adults
Kin Fai Ho, Ph.D.,
Assistant Professor, Jockey Club School of Public Health and Primary Care, the Chinese University of Hong Kong
1500-1530 Investigation of sleep quality in shipyard workers by wearable device
Hsiao-Chi Chuang, Ph.D.,
Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
1530-1600 Coffee Break

 Section
 III: Respiratory Therapy
Moderator: Bing-Chang Chen, Ph.D.,
Director, School of Respiratory Therapy, College of Medicine, Taipei Medical University
 
1600-1630 Current status of respiratory therapy profession and education system in Taiwan
Mauo-Ying Bien, Ph.D.,
Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
1630-1700 Meaningful outcomes for the long term ventilated patient at home
Chan Yeow, M.D.,
Director, Home Ventilation and Respiratory Support Service, Tan Tock Seng Hospital, Singapore
1700-1730 Pulmonary eehabilitation in pateints with COPD
Shu-Chuan Ho, Ph.D.,
Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
1730-1800 Inflammation induced airway hypersensitivity
Chun-Chun Hsu, Ph.D.,
Assistant Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University
1800-1830 General Discussion

Friday, December 29, 2017

 Time Program 
 0830-0900 Registration

 Section
 IV: Tuberculosis
Moderator: Chen-Yuan Chiang, M.D., Ph.D.,
Associate Professor, Division of Pulmonary Medicine, Wan Fang Hospital, Taipei Medical University
 
0900-0930 Tuberculosis in Taiwan, the Impact of Population Aging
Chih-Hsin Lee, M.D., Ph.D.,
Assistant Professor, Division of Pulmonary Medicine, Wan Fang Hospital, Taipei Medical University
0930-1000 The role of DOT-Watcher 2 in Vietnam MDR-TB management
Dat Phan Thuong, MD., PhD.,
Head of MDR-TB department, Pham Ngoc Thach TB & lung diseases hospital, Vietnam
1000-1030

Tuberculosis – Complementary actions to national (VN) tuberculosis control program

Van Linh Pham, M.D., Ph.D.,
Associate Professor, Head of Pulmonary Medicine Department, Haiphong University Hospital, Vietnam

1030-1100
Coffee Break

 Section V: 
Idiopathic Pulmonary Fibrosis
Moderator: Chi-Li Chung, MD., PhD.,
Director of Division of Pulmonary Medicine, Taipei Medical University Hospital, Taipei Medical University
 
1100-1130 IPF perspectives and challenges
Kai-Ling Lee, MD.,
Division of Pulmonary Medicine, Taipei Medical University Hospital, Taipei Medical University
1130-1200 Overview of pathogenesis of IPF and emerging drug targets strategies
Kuan-Yuan Chen, M.D.,
ivision of Pulmonary Medicine, Shuang Ho Hospital, Taipei Medical University
1200-1230 Closing Remark